Andrew G Affleck
Overview
Explore the profile of Andrew G Affleck including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
3.
Ahmed A, Affleck A, Angus J, Assalman I, Baron S, Bewley A, et al.
Br J Dermatol
. 2022 May;
187(4):472-480.
PMID: 35582951
The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of delusional infestation (DI) in adults. Linked Comment: I. Coulson. Br J Dermatol 2022; 187:457.
4.
Butler T, Matin R, Affleck A, Fleming C, Bowling J
Dermatol Pract Concept
. 2015 Jun;
5(2):29-38.
PMID: 26114049
Background: Dermoscopy is a useful tool to aid diagnosis of pigmented and non-pigmented skin lesions, as well as many other dermatological conditions. Use of dermoscopy is increasing worldwide, but to...
5.
Haw W, Rakvit P, Fraser S, Affleck A, Holme S
Br J Gen Pract
. 2014 Jul;
64(625):e465-70.
PMID: 25071058
Background: In contrast with most published evidence, studies from north-east Scotland suggest that GPs may be as good at treating skin cancers in primary care as secondary care specialists. Aim:...
6.
7.
Affleck A, Bottomley J, Auland M, Jackson P, Ryttov J
Curr Med Res Opin
. 2010 Dec;
27(1):269-84.
PMID: 21142836
Objectives: To compare the cost effectiveness of the two-compound formulation (TCF) calcipotriol plus betamethasone dipropionate gel used first-, second- or third-line to standard topical treatments for moderately severe scalp psoriasis...
8.
9.
Ezughah F, Affleck A, Evans A, Ibbotson S, Fleming C
J Dermatolog Treat
. 2008 Jun;
19(3):156-8.
PMID: 18569271
Background: Although the effectiveness of daily dosing regimens of 5% imiquimod cream for the treatment of superficial basal cell carcinomas (sBCC) has been documented by recent studies, concerns about long-term...
10.
Cohen S, Affleck A, Littlewood S
Br J Hosp Med (Lond)
. 2008 Jan;
68(12):680.
PMID: 18186413
No abstract available.